Global Liquid Biopsy Products Supply, Demand and Key Producers, 2026-2032
The global Liquid Biopsy Products market size is expected to reach $ 15888 million by 2032, rising at a market growth of 18.8% CAGR during the forecast period (2026-2032).
Liquid biopsy products refer to a category of in vitro diagnostic tools that non-invasively analyze biomarkers such as circulating tumor DNA (ctDNA), circulating tumor cells (CTCs), and exosomes from blood, urine, or other body fluids for cancer screening, diagnosis, treatment monitoring, and recurrence prediction. These products span key steps such as sample collection, preservation, nucleic acid extraction, target detection, and data interpretation. Compared to traditional tissue biopsy, liquid biopsy offers advantages in safety, repeatability, and applicability across various cancer types, making it increasingly adopted in clinical settings and showing great potential in precision and personalized medicine.The average gross profit margin of this product is 65%.
The rapid global advancement of precision medicine and rising cancer incidence form a strong foundation for liquid biopsy adoption. National healthcare systems are increasingly incorporating liquid biopsy into cancer screening and targeted therapy workflows. The declining cost of next-generation sequencing (NGS) and enhanced interpretation capabilities through AI are accelerating product entry into multi-cancer detection and multicenter clinical validation.
Despite increasing technological maturity, liquid biopsy still faces challenges in balancing sensitivity and specificity, especially for early-stage cancer detection. Non-uniform standards in sample processing and reagent quality across upstream and downstream components complicate clinical translation. Regulatory hurdles around privacy and bioethics remain significant barriers for global expansion. Broker analyses highlight that most revenue still stems from research-grade orders, and wider clinical adoption and reimbursement pathways require further development.
Demand for liquid biopsy is rapidly shifting from research use to routine clinical applications. Monitoring therapeutic response and early relapse detection in high-incidence cancers—such as lung, breast, and colorectal—are driving hospital procurement. Collaboration between biotech companies and hospitals is deepening, with joint labs and multicenter studies becoming the norm. Annual reports also reflect growing patient awareness and preference for non-invasive testing, spurring product expansion into home-testing and mobile diagnostic scenarios.
This report studies the global Liquid Biopsy Products demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Liquid Biopsy Products, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Liquid Biopsy Products that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Liquid Biopsy Products total market, 2021-2032, (USD Million)
Global Liquid Biopsy Products total market by region & country, CAGR, 2021-2032, (USD Million)
U.S. VS China: Liquid Biopsy Products total market, key domestic companies, and share, (USD Million)
Global Liquid Biopsy Products revenue by player, revenue and market share 2021-2026, (USD Million)
Global Liquid Biopsy Products total market by Type, CAGR, 2021-2032, (USD Million)
Global Liquid Biopsy Products total market by Application, CAGR, 2021-2032, (USD Million)
This report profiles major players in the global Liquid Biopsy Products market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Roche, Illumina, Qiagen, Guardant Health, MDxHealth, Pathway Genomics, NeoGenomics Laboraories, Novogen, BGI, Myriad Genetics, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world Liquid Biopsy Products market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Liquid Biopsy Products Market, By Region:
1. How big is the global Liquid Biopsy Products market?
2. What is the demand of the global Liquid Biopsy Products market?
3. What is the year over year growth of the global Liquid Biopsy Products market?
4. What is the total value of the global Liquid Biopsy Products market?
5. Who are the Major Players in the global Liquid Biopsy Products market?
6. What are the growth factors driving the market demand?
Liquid biopsy products refer to a category of in vitro diagnostic tools that non-invasively analyze biomarkers such as circulating tumor DNA (ctDNA), circulating tumor cells (CTCs), and exosomes from blood, urine, or other body fluids for cancer screening, diagnosis, treatment monitoring, and recurrence prediction. These products span key steps such as sample collection, preservation, nucleic acid extraction, target detection, and data interpretation. Compared to traditional tissue biopsy, liquid biopsy offers advantages in safety, repeatability, and applicability across various cancer types, making it increasingly adopted in clinical settings and showing great potential in precision and personalized medicine.The average gross profit margin of this product is 65%.
The rapid global advancement of precision medicine and rising cancer incidence form a strong foundation for liquid biopsy adoption. National healthcare systems are increasingly incorporating liquid biopsy into cancer screening and targeted therapy workflows. The declining cost of next-generation sequencing (NGS) and enhanced interpretation capabilities through AI are accelerating product entry into multi-cancer detection and multicenter clinical validation.
Despite increasing technological maturity, liquid biopsy still faces challenges in balancing sensitivity and specificity, especially for early-stage cancer detection. Non-uniform standards in sample processing and reagent quality across upstream and downstream components complicate clinical translation. Regulatory hurdles around privacy and bioethics remain significant barriers for global expansion. Broker analyses highlight that most revenue still stems from research-grade orders, and wider clinical adoption and reimbursement pathways require further development.
Demand for liquid biopsy is rapidly shifting from research use to routine clinical applications. Monitoring therapeutic response and early relapse detection in high-incidence cancers—such as lung, breast, and colorectal—are driving hospital procurement. Collaboration between biotech companies and hospitals is deepening, with joint labs and multicenter studies becoming the norm. Annual reports also reflect growing patient awareness and preference for non-invasive testing, spurring product expansion into home-testing and mobile diagnostic scenarios.
This report studies the global Liquid Biopsy Products demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Liquid Biopsy Products, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Liquid Biopsy Products that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Liquid Biopsy Products total market, 2021-2032, (USD Million)
Global Liquid Biopsy Products total market by region & country, CAGR, 2021-2032, (USD Million)
U.S. VS China: Liquid Biopsy Products total market, key domestic companies, and share, (USD Million)
Global Liquid Biopsy Products revenue by player, revenue and market share 2021-2026, (USD Million)
Global Liquid Biopsy Products total market by Type, CAGR, 2021-2032, (USD Million)
Global Liquid Biopsy Products total market by Application, CAGR, 2021-2032, (USD Million)
This report profiles major players in the global Liquid Biopsy Products market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Roche, Illumina, Qiagen, Guardant Health, MDxHealth, Pathway Genomics, NeoGenomics Laboraories, Novogen, BGI, Myriad Genetics, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world Liquid Biopsy Products market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Liquid Biopsy Products Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- CTCs
- ctDNA
- Exosomes
- NGS Sequencing
- Digital PCR
- Real-time PCR
- Other
- Blood Sample
- Urine Sample
- Other
- Hospitals and Clinics
- Third-party Laboratories
- Other
- Roche
- Illumina
- Qiagen
- Guardant Health
- MDxHealth
- Pathway Genomics
- NeoGenomics Laboraories
- Novogen
- BGI
- Myriad Genetics
- Adaptive Biotechnologies
- Biocept
- Angle plc
- Exact Sciences
- Natera
- Freenome
- Aide Bio
- Thermo Fisher Scientific
1. How big is the global Liquid Biopsy Products market?
2. What is the demand of the global Liquid Biopsy Products market?
3. What is the year over year growth of the global Liquid Biopsy Products market?
4. What is the total value of the global Liquid Biopsy Products market?
5. Who are the Major Players in the global Liquid Biopsy Products market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Liquid Biopsy Products Introduction
1.2 World Liquid Biopsy Products Market Size & Forecast (2021 & 2025 & 2032)
1.3 World Liquid Biopsy Products Total Market by Region (by Headquarter Location)
1.3.1 World Liquid Biopsy Products Market Size by Region (2021-2032), (by Headquarter Location)
1.3.2 United States Based Company Liquid Biopsy Products Revenue (2021-2032)
1.3.3 China Based Company Liquid Biopsy Products Revenue (2021-2032)
1.3.4 Europe Based Company Liquid Biopsy Products Revenue (2021-2032)
1.3.5 Japan Based Company Liquid Biopsy Products Revenue (2021-2032)
1.3.6 South Korea Based Company Liquid Biopsy Products Revenue (2021-2032)
1.3.7 ASEAN Based Company Liquid Biopsy Products Revenue (2021-2032)
1.3.8 India Based Company Liquid Biopsy Products Revenue (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Liquid Biopsy Products Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Major Market Trends
2 DEMAND SUMMARY
2.1 World Liquid Biopsy Products Consumption Value (2021-2032)
2.2 World Liquid Biopsy Products Consumption Value by Region
2.2.1 World Liquid Biopsy Products Consumption Value by Region (2021-2026)
2.2.2 World Liquid Biopsy Products Consumption Value Forecast by Region (2027-2032)
2.3 United States Liquid Biopsy Products Consumption Value (2021-2032)
2.4 China Liquid Biopsy Products Consumption Value (2021-2032)
2.5 Europe Liquid Biopsy Products Consumption Value (2021-2032)
2.6 Japan Liquid Biopsy Products Consumption Value (2021-2032)
2.7 South Korea Liquid Biopsy Products Consumption Value (2021-2032)
2.8 ASEAN Liquid Biopsy Products Consumption Value (2021-2032)
2.9 India Liquid Biopsy Products Consumption Value (2021-2032)
3 WORLD LIQUID BIOPSY PRODUCTS COMPANIES COMPETITIVE ANALYSIS
3.1 World Liquid Biopsy Products Revenue by Player (2021-2026)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Liquid Biopsy Products Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Liquid Biopsy Products in 2025
3.2.3 Global Concentration Ratios (CR8) for Liquid Biopsy Products in 2025
3.3 Liquid Biopsy Products Company Evaluation Quadrant
3.4 Liquid Biopsy Products Market: Overall Company Footprint Analysis
3.4.1 Liquid Biopsy Products Market: Region Footprint
3.4.2 Liquid Biopsy Products Market: Company Product Type Footprint
3.4.3 Liquid Biopsy Products Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers & Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Liquid Biopsy Products Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Liquid Biopsy Products Revenue Comparison (2021 & 2025 & 2032) (by Headquarter Location)
4.1.2 United States VS China: Liquid Biopsy Products Revenue Market Share Comparison (2021 & 2025 & 2032)
4.2 United States Based Companies VS China Based Companies: Liquid Biopsy Products Consumption Value Comparison
4.2.1 United States VS China: Liquid Biopsy Products Consumption Value Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Liquid Biopsy Products Consumption Value Market Share Comparison (2021 & 2025 & 2032)
4.3 United States Based Liquid Biopsy Products Companies and Market Share, 2021-2026
4.3.1 United States Based Liquid Biopsy Products Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Liquid Biopsy Products Revenue, (2021-2026)
4.4 China Based Companies Liquid Biopsy Products Revenue and Market Share, 2021-2026
4.4.1 China Based Liquid Biopsy Products Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Liquid Biopsy Products Revenue, (2021-2026)
4.5 Rest of World Based Liquid Biopsy Products Companies and Market Share, 2021-2026
4.5.1 Rest of World Based Liquid Biopsy Products Companies, Headquarters (Province, Country)
4.5.2 Rest of World Based Companies Liquid Biopsy Products Revenue (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Liquid Biopsy Products Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 CTCs
5.2.2 ctDNA
5.2.3 Exosomes
5.3 Market Segment by Type
5.3.1 World Liquid Biopsy Products Market Size by Type (2021-2026)
5.3.2 World Liquid Biopsy Products Market Size by Type (2027-2032)
5.3.3 World Liquid Biopsy Products Market Size Market Share by Type (2027-2032)
6 MARKET ANALYSIS BY TECHNOLOGY PLATFORM
6.1 World Liquid Biopsy Products Market Size Overview by Technology Platform: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Technology Platform
6.2.1 NGS Sequencing
6.2.2 Digital PCR
6.2.3 Real-time PCR
6.2.4 Other
6.3 Market Segment by Technology Platform
6.3.1 World Liquid Biopsy Products Market Size by Technology Platform (2021-2026)
6.3.2 World Liquid Biopsy Products Market Size by Technology Platform (2027-2032)
6.3.3 World Liquid Biopsy Products Market Size Market Share by Technology Platform (2027-2032)
7 MARKET ANALYSIS BY SAMPLE
7.1 World Liquid Biopsy Products Market Size Overview by Sample: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Sample
7.2.1 Blood Sample
7.2.2 Urine Sample
7.2.3 Other
7.3 Market Segment by Sample
7.3.1 World Liquid Biopsy Products Market Size by Sample (2021-2026)
7.3.2 World Liquid Biopsy Products Market Size by Sample (2027-2032)
7.3.3 World Liquid Biopsy Products Market Size Market Share by Sample (2027-2032)
8 MARKET ANALYSIS BY APPLICATION
8.1 World Liquid Biopsy Products Market Size Overview by Application: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Application
8.2.1 Hospitals and Clinics
8.2.2 Third-party Laboratories
8.2.3 Other
8.3 Market Segment by Application
8.3.1 World Liquid Biopsy Products Market Size by Application (2021-2026)
8.3.2 World Liquid Biopsy Products Market Size by Application (2027-2032)
8.3.3 World Liquid Biopsy Products Market Size Market Share by Application (2021-2032)
9 COMPANY PROFILES
9.1 Roche
9.1.1 Roche Details
9.1.2 Roche Major Business
9.1.3 Roche Liquid Biopsy Products Product and Services
9.1.4 Roche Liquid Biopsy Products Revenue, Gross Margin and Market Share (2021-2026)
9.1.5 Roche Recent Developments/Updates
9.1.6 Roche Competitive Strengths & Weaknesses
9.2 Illumina
9.2.1 Illumina Details
9.2.2 Illumina Major Business
9.2.3 Illumina Liquid Biopsy Products Product and Services
9.2.4 Illumina Liquid Biopsy Products Revenue, Gross Margin and Market Share (2021-2026)
9.2.5 Illumina Recent Developments/Updates
9.2.6 Illumina Competitive Strengths & Weaknesses
9.3 Qiagen
9.3.1 Qiagen Details
9.3.2 Qiagen Major Business
9.3.3 Qiagen Liquid Biopsy Products Product and Services
9.3.4 Qiagen Liquid Biopsy Products Revenue, Gross Margin and Market Share (2021-2026)
9.3.5 Qiagen Recent Developments/Updates
9.3.6 Qiagen Competitive Strengths & Weaknesses
9.4 Guardant Health
9.4.1 Guardant Health Details
9.4.2 Guardant Health Major Business
9.4.3 Guardant Health Liquid Biopsy Products Product and Services
9.4.4 Guardant Health Liquid Biopsy Products Revenue, Gross Margin and Market Share (2021-2026)
9.4.5 Guardant Health Recent Developments/Updates
9.4.6 Guardant Health Competitive Strengths & Weaknesses
9.5 MDxHealth
9.5.1 MDxHealth Details
9.5.2 MDxHealth Major Business
9.5.3 MDxHealth Liquid Biopsy Products Product and Services
9.5.4 MDxHealth Liquid Biopsy Products Revenue, Gross Margin and Market Share (2021-2026)
9.5.5 MDxHealth Recent Developments/Updates
9.5.6 MDxHealth Competitive Strengths & Weaknesses
9.6 Pathway Genomics
9.6.1 Pathway Genomics Details
9.6.2 Pathway Genomics Major Business
9.6.3 Pathway Genomics Liquid Biopsy Products Product and Services
9.6.4 Pathway Genomics Liquid Biopsy Products Revenue, Gross Margin and Market Share (2021-2026)
9.6.5 Pathway Genomics Recent Developments/Updates
9.6.6 Pathway Genomics Competitive Strengths & Weaknesses
9.7 NeoGenomics Laboraories
9.7.1 NeoGenomics Laboraories Details
9.7.2 NeoGenomics Laboraories Major Business
9.7.3 NeoGenomics Laboraories Liquid Biopsy Products Product and Services
9.7.4 NeoGenomics Laboraories Liquid Biopsy Products Revenue, Gross Margin and Market Share (2021-2026)
9.7.5 NeoGenomics Laboraories Recent Developments/Updates
9.7.6 NeoGenomics Laboraories Competitive Strengths & Weaknesses
9.8 Novogen
9.8.1 Novogen Details
9.8.2 Novogen Major Business
9.8.3 Novogen Liquid Biopsy Products Product and Services
9.8.4 Novogen Liquid Biopsy Products Revenue, Gross Margin and Market Share (2021-2026)
9.8.5 Novogen Recent Developments/Updates
9.8.6 Novogen Competitive Strengths & Weaknesses
9.9 BGI
9.9.1 BGI Details
9.9.2 BGI Major Business
9.9.3 BGI Liquid Biopsy Products Product and Services
9.9.4 BGI Liquid Biopsy Products Revenue, Gross Margin and Market Share (2021-2026)
9.9.5 BGI Recent Developments/Updates
9.9.6 BGI Competitive Strengths & Weaknesses
9.10 Myriad Genetics
9.10.1 Myriad Genetics Details
9.10.2 Myriad Genetics Major Business
9.10.3 Myriad Genetics Liquid Biopsy Products Product and Services
9.10.4 Myriad Genetics Liquid Biopsy Products Revenue, Gross Margin and Market Share (2021-2026)
9.10.5 Myriad Genetics Recent Developments/Updates
9.10.6 Myriad Genetics Competitive Strengths & Weaknesses
9.11 Adaptive Biotechnologies
9.11.1 Adaptive Biotechnologies Details
9.11.2 Adaptive Biotechnologies Major Business
9.11.3 Adaptive Biotechnologies Liquid Biopsy Products Product and Services
9.11.4 Adaptive Biotechnologies Liquid Biopsy Products Revenue, Gross Margin and Market Share (2021-2026)
9.11.5 Adaptive Biotechnologies Recent Developments/Updates
9.11.6 Adaptive Biotechnologies Competitive Strengths & Weaknesses
9.12 Biocept
9.12.1 Biocept Details
9.12.2 Biocept Major Business
9.12.3 Biocept Liquid Biopsy Products Product and Services
9.12.4 Biocept Liquid Biopsy Products Revenue, Gross Margin and Market Share (2021-2026)
9.12.5 Biocept Recent Developments/Updates
9.12.6 Biocept Competitive Strengths & Weaknesses
9.13 Angle plc
9.13.1 Angle plc Details
9.13.2 Angle plc Major Business
9.13.3 Angle plc Liquid Biopsy Products Product and Services
9.13.4 Angle plc Liquid Biopsy Products Revenue, Gross Margin and Market Share (2021-2026)
9.13.5 Angle plc Recent Developments/Updates
9.13.6 Angle plc Competitive Strengths & Weaknesses
9.14 Exact Sciences
9.14.1 Exact Sciences Details
9.14.2 Exact Sciences Major Business
9.14.3 Exact Sciences Liquid Biopsy Products Product and Services
9.14.4 Exact Sciences Liquid Biopsy Products Revenue, Gross Margin and Market Share (2021-2026)
9.14.5 Exact Sciences Recent Developments/Updates
9.14.6 Exact Sciences Competitive Strengths & Weaknesses
9.15 Natera
9.15.1 Natera Details
9.15.2 Natera Major Business
9.15.3 Natera Liquid Biopsy Products Product and Services
9.15.4 Natera Liquid Biopsy Products Revenue, Gross Margin and Market Share (2021-2026)
9.15.5 Natera Recent Developments/Updates
9.15.6 Natera Competitive Strengths & Weaknesses
9.16 Freenome
9.16.1 Freenome Details
9.16.2 Freenome Major Business
9.16.3 Freenome Liquid Biopsy Products Product and Services
9.16.4 Freenome Liquid Biopsy Products Revenue, Gross Margin and Market Share (2021-2026)
9.16.5 Freenome Recent Developments/Updates
9.16.6 Freenome Competitive Strengths & Weaknesses
9.17 Aide Bio
9.17.1 Aide Bio Details
9.17.2 Aide Bio Major Business
9.17.3 Aide Bio Liquid Biopsy Products Product and Services
9.17.4 Aide Bio Liquid Biopsy Products Revenue, Gross Margin and Market Share (2021-2026)
9.17.5 Aide Bio Recent Developments/Updates
9.17.6 Aide Bio Competitive Strengths & Weaknesses
9.18 Thermo Fisher Scientific
9.18.1 Thermo Fisher Scientific Details
9.18.2 Thermo Fisher Scientific Major Business
9.18.3 Thermo Fisher Scientific Liquid Biopsy Products Product and Services
9.18.4 Thermo Fisher Scientific Liquid Biopsy Products Revenue, Gross Margin and Market Share (2021-2026)
9.18.5 Thermo Fisher Scientific Recent Developments/Updates
9.18.6 Thermo Fisher Scientific Competitive Strengths & Weaknesses
10 INDUSTRY CHAIN ANALYSIS
10.1 Liquid Biopsy Products Industry Chain
10.2 Liquid Biopsy Products Upstream Analysis
10.3 Liquid Biopsy Products Midstream Analysis
10.4 Liquid Biopsy Products Downstream Analysis
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
1.1 Liquid Biopsy Products Introduction
1.2 World Liquid Biopsy Products Market Size & Forecast (2021 & 2025 & 2032)
1.3 World Liquid Biopsy Products Total Market by Region (by Headquarter Location)
1.3.1 World Liquid Biopsy Products Market Size by Region (2021-2032), (by Headquarter Location)
1.3.2 United States Based Company Liquid Biopsy Products Revenue (2021-2032)
1.3.3 China Based Company Liquid Biopsy Products Revenue (2021-2032)
1.3.4 Europe Based Company Liquid Biopsy Products Revenue (2021-2032)
1.3.5 Japan Based Company Liquid Biopsy Products Revenue (2021-2032)
1.3.6 South Korea Based Company Liquid Biopsy Products Revenue (2021-2032)
1.3.7 ASEAN Based Company Liquid Biopsy Products Revenue (2021-2032)
1.3.8 India Based Company Liquid Biopsy Products Revenue (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Liquid Biopsy Products Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Major Market Trends
2 DEMAND SUMMARY
2.1 World Liquid Biopsy Products Consumption Value (2021-2032)
2.2 World Liquid Biopsy Products Consumption Value by Region
2.2.1 World Liquid Biopsy Products Consumption Value by Region (2021-2026)
2.2.2 World Liquid Biopsy Products Consumption Value Forecast by Region (2027-2032)
2.3 United States Liquid Biopsy Products Consumption Value (2021-2032)
2.4 China Liquid Biopsy Products Consumption Value (2021-2032)
2.5 Europe Liquid Biopsy Products Consumption Value (2021-2032)
2.6 Japan Liquid Biopsy Products Consumption Value (2021-2032)
2.7 South Korea Liquid Biopsy Products Consumption Value (2021-2032)
2.8 ASEAN Liquid Biopsy Products Consumption Value (2021-2032)
2.9 India Liquid Biopsy Products Consumption Value (2021-2032)
3 WORLD LIQUID BIOPSY PRODUCTS COMPANIES COMPETITIVE ANALYSIS
3.1 World Liquid Biopsy Products Revenue by Player (2021-2026)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Liquid Biopsy Products Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Liquid Biopsy Products in 2025
3.2.3 Global Concentration Ratios (CR8) for Liquid Biopsy Products in 2025
3.3 Liquid Biopsy Products Company Evaluation Quadrant
3.4 Liquid Biopsy Products Market: Overall Company Footprint Analysis
3.4.1 Liquid Biopsy Products Market: Region Footprint
3.4.2 Liquid Biopsy Products Market: Company Product Type Footprint
3.4.3 Liquid Biopsy Products Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers & Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Liquid Biopsy Products Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Liquid Biopsy Products Revenue Comparison (2021 & 2025 & 2032) (by Headquarter Location)
4.1.2 United States VS China: Liquid Biopsy Products Revenue Market Share Comparison (2021 & 2025 & 2032)
4.2 United States Based Companies VS China Based Companies: Liquid Biopsy Products Consumption Value Comparison
4.2.1 United States VS China: Liquid Biopsy Products Consumption Value Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Liquid Biopsy Products Consumption Value Market Share Comparison (2021 & 2025 & 2032)
4.3 United States Based Liquid Biopsy Products Companies and Market Share, 2021-2026
4.3.1 United States Based Liquid Biopsy Products Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Liquid Biopsy Products Revenue, (2021-2026)
4.4 China Based Companies Liquid Biopsy Products Revenue and Market Share, 2021-2026
4.4.1 China Based Liquid Biopsy Products Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Liquid Biopsy Products Revenue, (2021-2026)
4.5 Rest of World Based Liquid Biopsy Products Companies and Market Share, 2021-2026
4.5.1 Rest of World Based Liquid Biopsy Products Companies, Headquarters (Province, Country)
4.5.2 Rest of World Based Companies Liquid Biopsy Products Revenue (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Liquid Biopsy Products Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 CTCs
5.2.2 ctDNA
5.2.3 Exosomes
5.3 Market Segment by Type
5.3.1 World Liquid Biopsy Products Market Size by Type (2021-2026)
5.3.2 World Liquid Biopsy Products Market Size by Type (2027-2032)
5.3.3 World Liquid Biopsy Products Market Size Market Share by Type (2027-2032)
6 MARKET ANALYSIS BY TECHNOLOGY PLATFORM
6.1 World Liquid Biopsy Products Market Size Overview by Technology Platform: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Technology Platform
6.2.1 NGS Sequencing
6.2.2 Digital PCR
6.2.3 Real-time PCR
6.2.4 Other
6.3 Market Segment by Technology Platform
6.3.1 World Liquid Biopsy Products Market Size by Technology Platform (2021-2026)
6.3.2 World Liquid Biopsy Products Market Size by Technology Platform (2027-2032)
6.3.3 World Liquid Biopsy Products Market Size Market Share by Technology Platform (2027-2032)
7 MARKET ANALYSIS BY SAMPLE
7.1 World Liquid Biopsy Products Market Size Overview by Sample: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Sample
7.2.1 Blood Sample
7.2.2 Urine Sample
7.2.3 Other
7.3 Market Segment by Sample
7.3.1 World Liquid Biopsy Products Market Size by Sample (2021-2026)
7.3.2 World Liquid Biopsy Products Market Size by Sample (2027-2032)
7.3.3 World Liquid Biopsy Products Market Size Market Share by Sample (2027-2032)
8 MARKET ANALYSIS BY APPLICATION
8.1 World Liquid Biopsy Products Market Size Overview by Application: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Application
8.2.1 Hospitals and Clinics
8.2.2 Third-party Laboratories
8.2.3 Other
8.3 Market Segment by Application
8.3.1 World Liquid Biopsy Products Market Size by Application (2021-2026)
8.3.2 World Liquid Biopsy Products Market Size by Application (2027-2032)
8.3.3 World Liquid Biopsy Products Market Size Market Share by Application (2021-2032)
9 COMPANY PROFILES
9.1 Roche
9.1.1 Roche Details
9.1.2 Roche Major Business
9.1.3 Roche Liquid Biopsy Products Product and Services
9.1.4 Roche Liquid Biopsy Products Revenue, Gross Margin and Market Share (2021-2026)
9.1.5 Roche Recent Developments/Updates
9.1.6 Roche Competitive Strengths & Weaknesses
9.2 Illumina
9.2.1 Illumina Details
9.2.2 Illumina Major Business
9.2.3 Illumina Liquid Biopsy Products Product and Services
9.2.4 Illumina Liquid Biopsy Products Revenue, Gross Margin and Market Share (2021-2026)
9.2.5 Illumina Recent Developments/Updates
9.2.6 Illumina Competitive Strengths & Weaknesses
9.3 Qiagen
9.3.1 Qiagen Details
9.3.2 Qiagen Major Business
9.3.3 Qiagen Liquid Biopsy Products Product and Services
9.3.4 Qiagen Liquid Biopsy Products Revenue, Gross Margin and Market Share (2021-2026)
9.3.5 Qiagen Recent Developments/Updates
9.3.6 Qiagen Competitive Strengths & Weaknesses
9.4 Guardant Health
9.4.1 Guardant Health Details
9.4.2 Guardant Health Major Business
9.4.3 Guardant Health Liquid Biopsy Products Product and Services
9.4.4 Guardant Health Liquid Biopsy Products Revenue, Gross Margin and Market Share (2021-2026)
9.4.5 Guardant Health Recent Developments/Updates
9.4.6 Guardant Health Competitive Strengths & Weaknesses
9.5 MDxHealth
9.5.1 MDxHealth Details
9.5.2 MDxHealth Major Business
9.5.3 MDxHealth Liquid Biopsy Products Product and Services
9.5.4 MDxHealth Liquid Biopsy Products Revenue, Gross Margin and Market Share (2021-2026)
9.5.5 MDxHealth Recent Developments/Updates
9.5.6 MDxHealth Competitive Strengths & Weaknesses
9.6 Pathway Genomics
9.6.1 Pathway Genomics Details
9.6.2 Pathway Genomics Major Business
9.6.3 Pathway Genomics Liquid Biopsy Products Product and Services
9.6.4 Pathway Genomics Liquid Biopsy Products Revenue, Gross Margin and Market Share (2021-2026)
9.6.5 Pathway Genomics Recent Developments/Updates
9.6.6 Pathway Genomics Competitive Strengths & Weaknesses
9.7 NeoGenomics Laboraories
9.7.1 NeoGenomics Laboraories Details
9.7.2 NeoGenomics Laboraories Major Business
9.7.3 NeoGenomics Laboraories Liquid Biopsy Products Product and Services
9.7.4 NeoGenomics Laboraories Liquid Biopsy Products Revenue, Gross Margin and Market Share (2021-2026)
9.7.5 NeoGenomics Laboraories Recent Developments/Updates
9.7.6 NeoGenomics Laboraories Competitive Strengths & Weaknesses
9.8 Novogen
9.8.1 Novogen Details
9.8.2 Novogen Major Business
9.8.3 Novogen Liquid Biopsy Products Product and Services
9.8.4 Novogen Liquid Biopsy Products Revenue, Gross Margin and Market Share (2021-2026)
9.8.5 Novogen Recent Developments/Updates
9.8.6 Novogen Competitive Strengths & Weaknesses
9.9 BGI
9.9.1 BGI Details
9.9.2 BGI Major Business
9.9.3 BGI Liquid Biopsy Products Product and Services
9.9.4 BGI Liquid Biopsy Products Revenue, Gross Margin and Market Share (2021-2026)
9.9.5 BGI Recent Developments/Updates
9.9.6 BGI Competitive Strengths & Weaknesses
9.10 Myriad Genetics
9.10.1 Myriad Genetics Details
9.10.2 Myriad Genetics Major Business
9.10.3 Myriad Genetics Liquid Biopsy Products Product and Services
9.10.4 Myriad Genetics Liquid Biopsy Products Revenue, Gross Margin and Market Share (2021-2026)
9.10.5 Myriad Genetics Recent Developments/Updates
9.10.6 Myriad Genetics Competitive Strengths & Weaknesses
9.11 Adaptive Biotechnologies
9.11.1 Adaptive Biotechnologies Details
9.11.2 Adaptive Biotechnologies Major Business
9.11.3 Adaptive Biotechnologies Liquid Biopsy Products Product and Services
9.11.4 Adaptive Biotechnologies Liquid Biopsy Products Revenue, Gross Margin and Market Share (2021-2026)
9.11.5 Adaptive Biotechnologies Recent Developments/Updates
9.11.6 Adaptive Biotechnologies Competitive Strengths & Weaknesses
9.12 Biocept
9.12.1 Biocept Details
9.12.2 Biocept Major Business
9.12.3 Biocept Liquid Biopsy Products Product and Services
9.12.4 Biocept Liquid Biopsy Products Revenue, Gross Margin and Market Share (2021-2026)
9.12.5 Biocept Recent Developments/Updates
9.12.6 Biocept Competitive Strengths & Weaknesses
9.13 Angle plc
9.13.1 Angle plc Details
9.13.2 Angle plc Major Business
9.13.3 Angle plc Liquid Biopsy Products Product and Services
9.13.4 Angle plc Liquid Biopsy Products Revenue, Gross Margin and Market Share (2021-2026)
9.13.5 Angle plc Recent Developments/Updates
9.13.6 Angle plc Competitive Strengths & Weaknesses
9.14 Exact Sciences
9.14.1 Exact Sciences Details
9.14.2 Exact Sciences Major Business
9.14.3 Exact Sciences Liquid Biopsy Products Product and Services
9.14.4 Exact Sciences Liquid Biopsy Products Revenue, Gross Margin and Market Share (2021-2026)
9.14.5 Exact Sciences Recent Developments/Updates
9.14.6 Exact Sciences Competitive Strengths & Weaknesses
9.15 Natera
9.15.1 Natera Details
9.15.2 Natera Major Business
9.15.3 Natera Liquid Biopsy Products Product and Services
9.15.4 Natera Liquid Biopsy Products Revenue, Gross Margin and Market Share (2021-2026)
9.15.5 Natera Recent Developments/Updates
9.15.6 Natera Competitive Strengths & Weaknesses
9.16 Freenome
9.16.1 Freenome Details
9.16.2 Freenome Major Business
9.16.3 Freenome Liquid Biopsy Products Product and Services
9.16.4 Freenome Liquid Biopsy Products Revenue, Gross Margin and Market Share (2021-2026)
9.16.5 Freenome Recent Developments/Updates
9.16.6 Freenome Competitive Strengths & Weaknesses
9.17 Aide Bio
9.17.1 Aide Bio Details
9.17.2 Aide Bio Major Business
9.17.3 Aide Bio Liquid Biopsy Products Product and Services
9.17.4 Aide Bio Liquid Biopsy Products Revenue, Gross Margin and Market Share (2021-2026)
9.17.5 Aide Bio Recent Developments/Updates
9.17.6 Aide Bio Competitive Strengths & Weaknesses
9.18 Thermo Fisher Scientific
9.18.1 Thermo Fisher Scientific Details
9.18.2 Thermo Fisher Scientific Major Business
9.18.3 Thermo Fisher Scientific Liquid Biopsy Products Product and Services
9.18.4 Thermo Fisher Scientific Liquid Biopsy Products Revenue, Gross Margin and Market Share (2021-2026)
9.18.5 Thermo Fisher Scientific Recent Developments/Updates
9.18.6 Thermo Fisher Scientific Competitive Strengths & Weaknesses
10 INDUSTRY CHAIN ANALYSIS
10.1 Liquid Biopsy Products Industry Chain
10.2 Liquid Biopsy Products Upstream Analysis
10.3 Liquid Biopsy Products Midstream Analysis
10.4 Liquid Biopsy Products Downstream Analysis
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
LIST OF TABLES
Table 1. World Liquid Biopsy Products Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Table 2. World Liquid Biopsy Products Revenue by Region (2021-2026) & (USD Million), (by Headquarter Location)
Table 3. World Liquid Biopsy Products Revenue by Region (2027-2032) & (USD Million), (by Headquarter Location)
Table 4. World Liquid Biopsy Products Revenue Market Share by Region (2021-2026), (by Headquarter Location)
Table 5. World Liquid Biopsy Products Revenue Market Share by Region (2027-2032), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Liquid Biopsy Products Consumption Value Growth Rate Forecast by Region (2021 & 2025 & 2032) & (USD Million)
Table 8. World Liquid Biopsy Products Consumption Value by Region (2021-2026) & (USD Million)
Table 9. World Liquid Biopsy Products Consumption Value Forecast by Region (2027-2032) & (USD Million)
Table 10. World Liquid Biopsy Products Revenue by Player (2021-2026) & (USD Million)
Table 11. Revenue Market Share of Key Liquid Biopsy Products Players in 2025
Table 12. World Liquid Biopsy Products Industry Rank of Major Player, Based on Revenue in 2025
Table 13. Global Liquid Biopsy Products Company Evaluation Quadrant
Table 14. Head Office of Key Liquid Biopsy Products Players
Table 15. Liquid Biopsy Products Market: Company Product Type Footprint
Table 16. Liquid Biopsy Products Market: Company Product Application Footprint
Table 17. Liquid Biopsy Products Mergers & Acquisitions Activity
Table 18. United States VS China Liquid Biopsy Products Revenue Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 19. United States VS China Liquid Biopsy Products Consumption Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 20. United States Based Liquid Biopsy Products Companies, Headquarters (States, Country)
Table 21. United States Based Companies Liquid Biopsy Products Revenue, (2021-2026) & (USD Million)
Table 22. United States Based Companies Liquid Biopsy Products Revenue Market Share (2021-2026)
Table 23. China Based Liquid Biopsy Products Companies, Headquarters (Province, Country)
Table 24. China Based Companies Liquid Biopsy Products Revenue, (2021-2026) & (USD Million)
Table 25. China Based Companies Liquid Biopsy Products Revenue Market Share (2021-2026)
Table 26. Rest of World Based Liquid Biopsy Products Companies, Headquarters (Province, Country)
Table 27. Rest of World Based Companies Liquid Biopsy Products Revenue (2021-2026) & (USD Million)
Table 28. Rest of World Based Companies Liquid Biopsy Products Revenue Market Share (2021-2026)
Table 29. World Liquid Biopsy Products Market Size by Type, (USD Million), 2021 & 2025 & 2032
Table 30. World Liquid Biopsy Products Market Size Value by Type (2021-2026) & (USD Million)
Table 31. World Liquid Biopsy Products Market Size by Type (2027-2032) & (USD Million)
Table 32. World Liquid Biopsy Products Market Size by Technology Platform, (USD Million), 2021 & 2025 & 2032
Table 33. World Liquid Biopsy Products Market Size Value by Technology Platform (2021-2026) & (USD Million)
Table 34. World Liquid Biopsy Products Market Size by Technology Platform (2027-2032) & (USD Million)
Table 35. World Liquid Biopsy Products Market Size by Sample, (USD Million), 2021 & 2025 & 2032
Table 36. World Liquid Biopsy Products Market Size Value by Sample (2021-2026) & (USD Million)
Table 37. World Liquid Biopsy Products Market Size by Sample (2027-2032) & (USD Million)
Table 38. World Liquid Biopsy Products Market Size by Application, (USD Million), 2021 & 2025 & 2032
Table 39. World Liquid Biopsy Products Market Size by Application (2021-2026) & (USD Million)
Table 40. World Liquid Biopsy Products Market Size by Application (2027-2032) & (USD Million)
Table 41. Roche Basic Information, Manufacturing Base and Competitors
Table 42. Roche Major Business
Table 43. Roche Liquid Biopsy Products Product and Services
Table 44. Roche Liquid Biopsy Products Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 45. Roche Recent Developments/Updates
Table 46. Roche Competitive Strengths & Weaknesses
Table 47. Illumina Basic Information, Manufacturing Base and Competitors
Table 48. Illumina Major Business
Table 49. Illumina Liquid Biopsy Products Product and Services
Table 50. Illumina Liquid Biopsy Products Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 51. Illumina Recent Developments/Updates
Table 52. Illumina Competitive Strengths & Weaknesses
Table 53. Qiagen Basic Information, Manufacturing Base and Competitors
Table 54. Qiagen Major Business
Table 55. Qiagen Liquid Biopsy Products Product and Services
Table 56. Qiagen Liquid Biopsy Products Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 57. Qiagen Recent Developments/Updates
Table 58. Qiagen Competitive Strengths & Weaknesses
Table 59. Guardant Health Basic Information, Manufacturing Base and Competitors
Table 60. Guardant Health Major Business
Table 61. Guardant Health Liquid Biopsy Products Product and Services
Table 62. Guardant Health Liquid Biopsy Products Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 63. Guardant Health Recent Developments/Updates
Table 64. Guardant Health Competitive Strengths & Weaknesses
Table 65. MDxHealth Basic Information, Manufacturing Base and Competitors
Table 66. MDxHealth Major Business
Table 67. MDxHealth Liquid Biopsy Products Product and Services
Table 68. MDxHealth Liquid Biopsy Products Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 69. MDxHealth Recent Developments/Updates
Table 70. MDxHealth Competitive Strengths & Weaknesses
Table 71. Pathway Genomics Basic Information, Manufacturing Base and Competitors
Table 72. Pathway Genomics Major Business
Table 73. Pathway Genomics Liquid Biopsy Products Product and Services
Table 74. Pathway Genomics Liquid Biopsy Products Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 75. Pathway Genomics Recent Developments/Updates
Table 76. Pathway Genomics Competitive Strengths & Weaknesses
Table 77. NeoGenomics Laboraories Basic Information, Manufacturing Base and Competitors
Table 78. NeoGenomics Laboraories Major Business
Table 79. NeoGenomics Laboraories Liquid Biopsy Products Product and Services
Table 80. NeoGenomics Laboraories Liquid Biopsy Products Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 81. NeoGenomics Laboraories Recent Developments/Updates
Table 82. NeoGenomics Laboraories Competitive Strengths & Weaknesses
Table 83. Novogen Basic Information, Manufacturing Base and Competitors
Table 84. Novogen Major Business
Table 85. Novogen Liquid Biopsy Products Product and Services
Table 86. Novogen Liquid Biopsy Products Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 87. Novogen Recent Developments/Updates
Table 88. Novogen Competitive Strengths & Weaknesses
Table 89. BGI Basic Information, Manufacturing Base and Competitors
Table 90. BGI Major Business
Table 91. BGI Liquid Biopsy Products Product and Services
Table 92. BGI Liquid Biopsy Products Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 93. BGI Recent Developments/Updates
Table 94. BGI Competitive Strengths & Weaknesses
Table 95. Myriad Genetics Basic Information, Manufacturing Base and Competitors
Table 96. Myriad Genetics Major Business
Table 97. Myriad Genetics Liquid Biopsy Products Product and Services
Table 98. Myriad Genetics Liquid Biopsy Products Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 99. Myriad Genetics Recent Developments/Updates
Table 100. Myriad Genetics Competitive Strengths & Weaknesses
Table 101. Adaptive Biotechnologies Basic Information, Manufacturing Base and Competitors
Table 102. Adaptive Biotechnologies Major Business
Table 103. Adaptive Biotechnologies Liquid Biopsy Products Product and Services
Table 104. Adaptive Biotechnologies Liquid Biopsy Products Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 105. Adaptive Biotechnologies Recent Developments/Updates
Table 106. Adaptive Biotechnologies Competitive Strengths & Weaknesses
Table 107. Biocept Basic Information, Manufacturing Base and Competitors
Table 108. Biocept Major Business
Table 109. Biocept Liquid Biopsy Products Product and Services
Table 110. Biocept Liquid Biopsy Products Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 111. Biocept Recent Developments/Updates
Table 112. Biocept Competitive Strengths & Weaknesses
Table 113. Angle plc Basic Information, Manufacturing Base and Competitors
Table 114. Angle plc Major Business
Table 115. Angle plc Liquid Biopsy Products Product and Services
Table 116. Angle plc Liquid Biopsy Products Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 117. Angle plc Recent Developments/Updates
Table 118. Angle plc Competitive Strengths & Weaknesses
Table 119. Exact Sciences Basic Information, Manufacturing Base and Competitors
Table 120. Exact Sciences Major Business
Table 121. Exact Sciences Liquid Biopsy Products Product and Services
Table 122. Exact Sciences Liquid Biopsy Products Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 123. Exact Sciences Recent Developments/Updates
Table 124. Exact Sciences Competitive Strengths & Weaknesses
Table 125. Natera Basic Information, Manufacturing Base and Competitors
Table 126. Natera Major Business
Table 127. Natera Liquid Biopsy Products Product and Services
Table 128. Natera Liquid Biopsy Products Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 129. Natera Recent Developments/Updates
Table 130. Natera Competitive Strengths & Weaknesses
Table 131. Freenome Basic Information, Manufacturing Base and Competitors
Table 132. Freenome Major Business
Table 133. Freenome Liquid Biopsy Products Product and Services
Table 134. Freenome Liquid Biopsy Products Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 135. Freenome Recent Developments/Updates
Table 136. Freenome Competitive Strengths & Weaknesses
Table 137. Aide Bio Basic Information, Manufacturing Base and Competitors
Table 138. Aide Bio Major Business
Table 139. Aide Bio Liquid Biopsy Products Product and Services
Table 140. Aide Bio Liquid Biopsy Products Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 141. Aide Bio Recent Developments/Updates
Table 142. Aide Bio Competitive Strengths & Weaknesses
Table 143. Thermo Fisher Scientific Basic Information, Manufacturing Base and Competitors
Table 144. Thermo Fisher Scientific Major Business
Table 145. Thermo Fisher Scientific Liquid Biopsy Products Product and Services
Table 146. Thermo Fisher Scientific Liquid Biopsy Products Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 147. Thermo Fisher Scientific Recent Developments/Updates
Table 148. Thermo Fisher Scientific Competitive Strengths & Weaknesses
Table 149. Global Key Players of Liquid Biopsy Products Upstream (Raw Materials)
Table 150. Global Liquid Biopsy Products Typical Customers
Table 1. World Liquid Biopsy Products Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Table 2. World Liquid Biopsy Products Revenue by Region (2021-2026) & (USD Million), (by Headquarter Location)
Table 3. World Liquid Biopsy Products Revenue by Region (2027-2032) & (USD Million), (by Headquarter Location)
Table 4. World Liquid Biopsy Products Revenue Market Share by Region (2021-2026), (by Headquarter Location)
Table 5. World Liquid Biopsy Products Revenue Market Share by Region (2027-2032), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Liquid Biopsy Products Consumption Value Growth Rate Forecast by Region (2021 & 2025 & 2032) & (USD Million)
Table 8. World Liquid Biopsy Products Consumption Value by Region (2021-2026) & (USD Million)
Table 9. World Liquid Biopsy Products Consumption Value Forecast by Region (2027-2032) & (USD Million)
Table 10. World Liquid Biopsy Products Revenue by Player (2021-2026) & (USD Million)
Table 11. Revenue Market Share of Key Liquid Biopsy Products Players in 2025
Table 12. World Liquid Biopsy Products Industry Rank of Major Player, Based on Revenue in 2025
Table 13. Global Liquid Biopsy Products Company Evaluation Quadrant
Table 14. Head Office of Key Liquid Biopsy Products Players
Table 15. Liquid Biopsy Products Market: Company Product Type Footprint
Table 16. Liquid Biopsy Products Market: Company Product Application Footprint
Table 17. Liquid Biopsy Products Mergers & Acquisitions Activity
Table 18. United States VS China Liquid Biopsy Products Revenue Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 19. United States VS China Liquid Biopsy Products Consumption Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 20. United States Based Liquid Biopsy Products Companies, Headquarters (States, Country)
Table 21. United States Based Companies Liquid Biopsy Products Revenue, (2021-2026) & (USD Million)
Table 22. United States Based Companies Liquid Biopsy Products Revenue Market Share (2021-2026)
Table 23. China Based Liquid Biopsy Products Companies, Headquarters (Province, Country)
Table 24. China Based Companies Liquid Biopsy Products Revenue, (2021-2026) & (USD Million)
Table 25. China Based Companies Liquid Biopsy Products Revenue Market Share (2021-2026)
Table 26. Rest of World Based Liquid Biopsy Products Companies, Headquarters (Province, Country)
Table 27. Rest of World Based Companies Liquid Biopsy Products Revenue (2021-2026) & (USD Million)
Table 28. Rest of World Based Companies Liquid Biopsy Products Revenue Market Share (2021-2026)
Table 29. World Liquid Biopsy Products Market Size by Type, (USD Million), 2021 & 2025 & 2032
Table 30. World Liquid Biopsy Products Market Size Value by Type (2021-2026) & (USD Million)
Table 31. World Liquid Biopsy Products Market Size by Type (2027-2032) & (USD Million)
Table 32. World Liquid Biopsy Products Market Size by Technology Platform, (USD Million), 2021 & 2025 & 2032
Table 33. World Liquid Biopsy Products Market Size Value by Technology Platform (2021-2026) & (USD Million)
Table 34. World Liquid Biopsy Products Market Size by Technology Platform (2027-2032) & (USD Million)
Table 35. World Liquid Biopsy Products Market Size by Sample, (USD Million), 2021 & 2025 & 2032
Table 36. World Liquid Biopsy Products Market Size Value by Sample (2021-2026) & (USD Million)
Table 37. World Liquid Biopsy Products Market Size by Sample (2027-2032) & (USD Million)
Table 38. World Liquid Biopsy Products Market Size by Application, (USD Million), 2021 & 2025 & 2032
Table 39. World Liquid Biopsy Products Market Size by Application (2021-2026) & (USD Million)
Table 40. World Liquid Biopsy Products Market Size by Application (2027-2032) & (USD Million)
Table 41. Roche Basic Information, Manufacturing Base and Competitors
Table 42. Roche Major Business
Table 43. Roche Liquid Biopsy Products Product and Services
Table 44. Roche Liquid Biopsy Products Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 45. Roche Recent Developments/Updates
Table 46. Roche Competitive Strengths & Weaknesses
Table 47. Illumina Basic Information, Manufacturing Base and Competitors
Table 48. Illumina Major Business
Table 49. Illumina Liquid Biopsy Products Product and Services
Table 50. Illumina Liquid Biopsy Products Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 51. Illumina Recent Developments/Updates
Table 52. Illumina Competitive Strengths & Weaknesses
Table 53. Qiagen Basic Information, Manufacturing Base and Competitors
Table 54. Qiagen Major Business
Table 55. Qiagen Liquid Biopsy Products Product and Services
Table 56. Qiagen Liquid Biopsy Products Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 57. Qiagen Recent Developments/Updates
Table 58. Qiagen Competitive Strengths & Weaknesses
Table 59. Guardant Health Basic Information, Manufacturing Base and Competitors
Table 60. Guardant Health Major Business
Table 61. Guardant Health Liquid Biopsy Products Product and Services
Table 62. Guardant Health Liquid Biopsy Products Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 63. Guardant Health Recent Developments/Updates
Table 64. Guardant Health Competitive Strengths & Weaknesses
Table 65. MDxHealth Basic Information, Manufacturing Base and Competitors
Table 66. MDxHealth Major Business
Table 67. MDxHealth Liquid Biopsy Products Product and Services
Table 68. MDxHealth Liquid Biopsy Products Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 69. MDxHealth Recent Developments/Updates
Table 70. MDxHealth Competitive Strengths & Weaknesses
Table 71. Pathway Genomics Basic Information, Manufacturing Base and Competitors
Table 72. Pathway Genomics Major Business
Table 73. Pathway Genomics Liquid Biopsy Products Product and Services
Table 74. Pathway Genomics Liquid Biopsy Products Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 75. Pathway Genomics Recent Developments/Updates
Table 76. Pathway Genomics Competitive Strengths & Weaknesses
Table 77. NeoGenomics Laboraories Basic Information, Manufacturing Base and Competitors
Table 78. NeoGenomics Laboraories Major Business
Table 79. NeoGenomics Laboraories Liquid Biopsy Products Product and Services
Table 80. NeoGenomics Laboraories Liquid Biopsy Products Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 81. NeoGenomics Laboraories Recent Developments/Updates
Table 82. NeoGenomics Laboraories Competitive Strengths & Weaknesses
Table 83. Novogen Basic Information, Manufacturing Base and Competitors
Table 84. Novogen Major Business
Table 85. Novogen Liquid Biopsy Products Product and Services
Table 86. Novogen Liquid Biopsy Products Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 87. Novogen Recent Developments/Updates
Table 88. Novogen Competitive Strengths & Weaknesses
Table 89. BGI Basic Information, Manufacturing Base and Competitors
Table 90. BGI Major Business
Table 91. BGI Liquid Biopsy Products Product and Services
Table 92. BGI Liquid Biopsy Products Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 93. BGI Recent Developments/Updates
Table 94. BGI Competitive Strengths & Weaknesses
Table 95. Myriad Genetics Basic Information, Manufacturing Base and Competitors
Table 96. Myriad Genetics Major Business
Table 97. Myriad Genetics Liquid Biopsy Products Product and Services
Table 98. Myriad Genetics Liquid Biopsy Products Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 99. Myriad Genetics Recent Developments/Updates
Table 100. Myriad Genetics Competitive Strengths & Weaknesses
Table 101. Adaptive Biotechnologies Basic Information, Manufacturing Base and Competitors
Table 102. Adaptive Biotechnologies Major Business
Table 103. Adaptive Biotechnologies Liquid Biopsy Products Product and Services
Table 104. Adaptive Biotechnologies Liquid Biopsy Products Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 105. Adaptive Biotechnologies Recent Developments/Updates
Table 106. Adaptive Biotechnologies Competitive Strengths & Weaknesses
Table 107. Biocept Basic Information, Manufacturing Base and Competitors
Table 108. Biocept Major Business
Table 109. Biocept Liquid Biopsy Products Product and Services
Table 110. Biocept Liquid Biopsy Products Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 111. Biocept Recent Developments/Updates
Table 112. Biocept Competitive Strengths & Weaknesses
Table 113. Angle plc Basic Information, Manufacturing Base and Competitors
Table 114. Angle plc Major Business
Table 115. Angle plc Liquid Biopsy Products Product and Services
Table 116. Angle plc Liquid Biopsy Products Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 117. Angle plc Recent Developments/Updates
Table 118. Angle plc Competitive Strengths & Weaknesses
Table 119. Exact Sciences Basic Information, Manufacturing Base and Competitors
Table 120. Exact Sciences Major Business
Table 121. Exact Sciences Liquid Biopsy Products Product and Services
Table 122. Exact Sciences Liquid Biopsy Products Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 123. Exact Sciences Recent Developments/Updates
Table 124. Exact Sciences Competitive Strengths & Weaknesses
Table 125. Natera Basic Information, Manufacturing Base and Competitors
Table 126. Natera Major Business
Table 127. Natera Liquid Biopsy Products Product and Services
Table 128. Natera Liquid Biopsy Products Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 129. Natera Recent Developments/Updates
Table 130. Natera Competitive Strengths & Weaknesses
Table 131. Freenome Basic Information, Manufacturing Base and Competitors
Table 132. Freenome Major Business
Table 133. Freenome Liquid Biopsy Products Product and Services
Table 134. Freenome Liquid Biopsy Products Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 135. Freenome Recent Developments/Updates
Table 136. Freenome Competitive Strengths & Weaknesses
Table 137. Aide Bio Basic Information, Manufacturing Base and Competitors
Table 138. Aide Bio Major Business
Table 139. Aide Bio Liquid Biopsy Products Product and Services
Table 140. Aide Bio Liquid Biopsy Products Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 141. Aide Bio Recent Developments/Updates
Table 142. Aide Bio Competitive Strengths & Weaknesses
Table 143. Thermo Fisher Scientific Basic Information, Manufacturing Base and Competitors
Table 144. Thermo Fisher Scientific Major Business
Table 145. Thermo Fisher Scientific Liquid Biopsy Products Product and Services
Table 146. Thermo Fisher Scientific Liquid Biopsy Products Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 147. Thermo Fisher Scientific Recent Developments/Updates
Table 148. Thermo Fisher Scientific Competitive Strengths & Weaknesses
Table 149. Global Key Players of Liquid Biopsy Products Upstream (Raw Materials)
Table 150. Global Liquid Biopsy Products Typical Customers
LIST OF FIGURES
Figure 1. Liquid Biopsy Products Picture
Figure 2. World Liquid Biopsy Products Total Revenue: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Liquid Biopsy Products Total Revenue (2021-2032) & (USD Million)
Figure 4. World Liquid Biopsy Products Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Figure 5. World Liquid Biopsy Products Revenue Market Share by Region (2021-2032), (by Headquarter Location)
Figure 6. United States Based Company Liquid Biopsy Products Revenue (2021-2032) & (USD Million)
Figure 7. China Based Company Liquid Biopsy Products Revenue (2021-2032) & (USD Million)
Figure 8. Europe Based Company Liquid Biopsy Products Revenue (2021-2032) & (USD Million)
Figure 9. Japan Based Company Liquid Biopsy Products Revenue (2021-2032) & (USD Million)
Figure 10. South Korea Based Company Liquid Biopsy Products Revenue (2021-2032) & (USD Million)
Figure 11. ASEAN Based Company Liquid Biopsy Products Revenue (2021-2032) & (USD Million)
Figure 12. India Based Company Liquid Biopsy Products Revenue (2021-2032) & (USD Million)
Figure 13. Liquid Biopsy Products Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Liquid Biopsy Products Consumption Value (2021-2032) & (USD Million)
Figure 16. World Liquid Biopsy Products Consumption Value Market Share by Region (2021-2032)
Figure 17. United States Liquid Biopsy Products Consumption Value (2021-2032) & (USD Million)
Figure 18. China Liquid Biopsy Products Consumption Value (2021-2032) & (USD Million)
Figure 19. Europe Liquid Biopsy Products Consumption Value (2021-2032) & (USD Million)
Figure 20. Japan Liquid Biopsy Products Consumption Value (2021-2032) & (USD Million)
Figure 21. South Korea Liquid Biopsy Products Consumption Value (2021-2032) & (USD Million)
Figure 22. ASEAN Liquid Biopsy Products Consumption Value (2021-2032) & (USD Million)
Figure 23. India Liquid Biopsy Products Consumption Value (2021-2032) & (USD Million)
Figure 24. Producer Shipments of Liquid Biopsy Products by Player Revenue ($MM) and Market Share (%): 2025
Figure 25. Global Four-firm Concentration Ratios (CR4) for Liquid Biopsy Products Markets in 2025
Figure 26. Global Four-firm Concentration Ratios (CR8) for Liquid Biopsy Products Markets in 2025
Figure 27. United States VS China: Liquid Biopsy Products Revenue Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Liquid Biopsy Products Consumption Value Market Share Comparison (2021 & 2025 & 2032)
Figure 29. World Liquid Biopsy Products Market Size by Type, (USD Million), 2021 & 2025 & 2032
Figure 30. World Liquid Biopsy Products Market Size Market Share by Type in 2025
Figure 31. CTCs
Figure 32. ctDNA
Figure 33. Exosomes
Figure 34. World Liquid Biopsy Products Market Size Market Share by Type (2021-2032)
Figure 35. World Liquid Biopsy Products Market Size by Technology Platform, (USD Million), 2021 & 2025 & 2032
Figure 36. World Liquid Biopsy Products Market Size Market Share by Technology Platform in 2025
Figure 37. NGS Sequencing
Figure 38. Digital PCR
Figure 39. Real-time PCR
Figure 40. Other
Figure 41. World Liquid Biopsy Products Market Size Market Share by Technology Platform (2021-2032)
Figure 42. World Liquid Biopsy Products Market Size by Sample, (USD Million), 2021 & 2025 & 2032
Figure 43. World Liquid Biopsy Products Market Size Market Share by Sample in 2025
Figure 44. Blood Sample
Figure 45. Urine Sample
Figure 46. Other
Figure 47. World Liquid Biopsy Products Market Size Market Share by Sample (2021-2032)
Figure 48. World Liquid Biopsy Products Market Size by Application, (USD Million), 2021 & 2025 & 2032
Figure 49. World Liquid Biopsy Products Market Size Market Share by Application in 2025
Figure 50. Hospitals and Clinics
Figure 51. Third-party Laboratories
Figure 52. Other
Figure 53. World Liquid Biopsy Products Market Size Market Share by Application (2021-2032)
Figure 54. Liquid Biopsy Products Industrial Chain
Figure 55. Methodology
Figure 56. Research Process and Data Source
Figure 1. Liquid Biopsy Products Picture
Figure 2. World Liquid Biopsy Products Total Revenue: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Liquid Biopsy Products Total Revenue (2021-2032) & (USD Million)
Figure 4. World Liquid Biopsy Products Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Figure 5. World Liquid Biopsy Products Revenue Market Share by Region (2021-2032), (by Headquarter Location)
Figure 6. United States Based Company Liquid Biopsy Products Revenue (2021-2032) & (USD Million)
Figure 7. China Based Company Liquid Biopsy Products Revenue (2021-2032) & (USD Million)
Figure 8. Europe Based Company Liquid Biopsy Products Revenue (2021-2032) & (USD Million)
Figure 9. Japan Based Company Liquid Biopsy Products Revenue (2021-2032) & (USD Million)
Figure 10. South Korea Based Company Liquid Biopsy Products Revenue (2021-2032) & (USD Million)
Figure 11. ASEAN Based Company Liquid Biopsy Products Revenue (2021-2032) & (USD Million)
Figure 12. India Based Company Liquid Biopsy Products Revenue (2021-2032) & (USD Million)
Figure 13. Liquid Biopsy Products Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Liquid Biopsy Products Consumption Value (2021-2032) & (USD Million)
Figure 16. World Liquid Biopsy Products Consumption Value Market Share by Region (2021-2032)
Figure 17. United States Liquid Biopsy Products Consumption Value (2021-2032) & (USD Million)
Figure 18. China Liquid Biopsy Products Consumption Value (2021-2032) & (USD Million)
Figure 19. Europe Liquid Biopsy Products Consumption Value (2021-2032) & (USD Million)
Figure 20. Japan Liquid Biopsy Products Consumption Value (2021-2032) & (USD Million)
Figure 21. South Korea Liquid Biopsy Products Consumption Value (2021-2032) & (USD Million)
Figure 22. ASEAN Liquid Biopsy Products Consumption Value (2021-2032) & (USD Million)
Figure 23. India Liquid Biopsy Products Consumption Value (2021-2032) & (USD Million)
Figure 24. Producer Shipments of Liquid Biopsy Products by Player Revenue ($MM) and Market Share (%): 2025
Figure 25. Global Four-firm Concentration Ratios (CR4) for Liquid Biopsy Products Markets in 2025
Figure 26. Global Four-firm Concentration Ratios (CR8) for Liquid Biopsy Products Markets in 2025
Figure 27. United States VS China: Liquid Biopsy Products Revenue Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Liquid Biopsy Products Consumption Value Market Share Comparison (2021 & 2025 & 2032)
Figure 29. World Liquid Biopsy Products Market Size by Type, (USD Million), 2021 & 2025 & 2032
Figure 30. World Liquid Biopsy Products Market Size Market Share by Type in 2025
Figure 31. CTCs
Figure 32. ctDNA
Figure 33. Exosomes
Figure 34. World Liquid Biopsy Products Market Size Market Share by Type (2021-2032)
Figure 35. World Liquid Biopsy Products Market Size by Technology Platform, (USD Million), 2021 & 2025 & 2032
Figure 36. World Liquid Biopsy Products Market Size Market Share by Technology Platform in 2025
Figure 37. NGS Sequencing
Figure 38. Digital PCR
Figure 39. Real-time PCR
Figure 40. Other
Figure 41. World Liquid Biopsy Products Market Size Market Share by Technology Platform (2021-2032)
Figure 42. World Liquid Biopsy Products Market Size by Sample, (USD Million), 2021 & 2025 & 2032
Figure 43. World Liquid Biopsy Products Market Size Market Share by Sample in 2025
Figure 44. Blood Sample
Figure 45. Urine Sample
Figure 46. Other
Figure 47. World Liquid Biopsy Products Market Size Market Share by Sample (2021-2032)
Figure 48. World Liquid Biopsy Products Market Size by Application, (USD Million), 2021 & 2025 & 2032
Figure 49. World Liquid Biopsy Products Market Size Market Share by Application in 2025
Figure 50. Hospitals and Clinics
Figure 51. Third-party Laboratories
Figure 52. Other
Figure 53. World Liquid Biopsy Products Market Size Market Share by Application (2021-2032)
Figure 54. Liquid Biopsy Products Industrial Chain
Figure 55. Methodology
Figure 56. Research Process and Data Source
